Inspired by Hope. Focused on Prevention. Powered by Innovation.

About Novavax

We are committed to delivering novel products that leverage our innovative proprietary recombinant nanoparticle vaccine technology to prevent a broad range of infectious diseases. We produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats.

Uniquely Qualified

*“We will draw on our experience in developing vaccine candidates for some of the world’s toughest viral threats and use the power of our innovative recombinant nanoparticle vaccine platform, fortified by our Matrix-M™ adjuvant, to address an urgent need—to reduce the human toll of vaccine-preventable diseases.”*

Stanley Erck
President and Chief Executive Officer
Novavax

Learn about

Recombinant nanoparticle platform

Adjuvant Matrix‑M™

Partners

Our Science

Resources

For Investors